Statistics

Total Visits

Views
Faldaprevir Plus Pegylated Interferon Alfa-2a and Ribavirin in Chronic HCV Genotype-1 Treatment-Naive Patients: Final Results from STARTVerso1: A Randomized, Double-blind, Placebo-Controlled, Phase 3 Trial81

Select a period of time:

Number of views in the range

Views
Faldaprevir Plus Pegylated Interferon Alfa-2a and Ribavirin in Chronic HCV Genotype-1 Treatment-Naive Patients: Final Results from STARTVerso1: A Randomized, Double-blind, Placebo-Controlled, Phase 3 Trial30

Views

Views
May 20259
June 20250
July 202513
August 20250
September 20257
October 20251
November 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States13
Italy7
Brazil4
South Africa3
Canada1
United Kingdom1
Turkey1
 

Top cities views

Views
Dallas6
Comabbio4
Milan3
Cape Town1
Chandler1
Columbus1
Duque de Caxias1
Johannesburg1
Malacacheta1
Orlando1